At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer Theresa Schwartz ASO Perspectives 12 February 2024 Pages: 2801 - 2803
Does Cancer Accreditation Designation Mean Better Quality Care and Long-Term Oncological Outcomes? Kathie-Ann Joseph Global Health Services Research 22 January 2024 Pages: 2804 - 2805
Differences in DVT Rates in Patients Treated With and Without Preoperative Chemotherapy Prior to Distal Pancreatectomy: Is it the Therapy or Disease Burden? Joshua N. HerbRebecca A. Snyder Pancreatic Tumors 20 January 2024 Pages: 2806 - 2808
Pancreatic Neuroendocrine Tumors and Lymph Nodes: How Much Surgery is Enough? Eric H. Liu Pancreatic Tumors 27 January 2024 Pages: 2809 - 2810
Editorial Comment on: Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway Takehiko Yokobori Gastrointestinal Oncology 12 February 2024 Pages: 2811 - 2812
Disease-Specific Surgical Benchmarking: A Nuanced Approach to Operative Outcomes Sanket Srinivasa Hepatobiliary Tumors 20 February 2024 Pages: 2813 - 2814
Comment on “Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study” Caroline Gronnier Thoracic Oncology 14 February 2024 Pages: 2815 - 2817
Surgical Resection Delays among Patients with Stage 1 Lung Cancer: A Study with Disaggregated Ethnic Groups Bahaa KazziNikhil P. MankuzhyEdward Christopher Dee ASO Research Letter 28 January 2024 Pages: 2818 - 2823
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer Brian BadgwellJeannelyn EstrellaPaul Mansfield ASO Research Letter 29 January 2024 Pages: 2824 - 2825
Understanding the Caregiver Perspective: The Impact of Caring for Patients with Advanced Cancer Beatrice J. SunByrne Lee ASO Research Letter 29 January 2024 Pages: 2826 - 2828
Surgical Oncology Heroes and Legends: Kirby I. Bland MD, FACS, MAMSE as Interviewed by V. Suzanne Klimberg, MD, PhD, MSHCT, MAMSE Kirby I. BlandV. Suzanne Klimberg Global Health Services Research 13 February 2024 Pages: 2829 - 2830
Surgical Oncology Heroes and Legends: Edward M. Copeland III, MD, as Interviewed by Kirby I. Bland, MD, FACS, MAMSE Edward M. Copeland IIIKirby I. Bland Global Health Services Research 28 February 2024 Pages: 2831 - 2832
Ernst Bertner: A Surgeon with Prescient Vision for the Largest Medical Center in the World Charles M. Balch Global Health Services Research 07 February 2024 Pages: 2833 - 2855
Variation in Hospital Mortality After Complex Cancer Surgery: Patient, Volume, Hospital or Social Determinants? Muhammad Musaab MunirSelamawit WoldesenbetTimothy M. Pawlik Global Health Services Research Open access 09 January 2024 Pages: 2856 - 2866
ASO Author Reflections: Variation in Hospital Mortality After Complex Cancer Surgery: Patient, Volume, Hospital, or Social Determinants? Muhammad Musaab MunirTimothy M. Pawlik ASO Author Reflections Open access 11 January 2024 Pages: 2867 - 2868
ASO Visual Abstract: Variation in Hospital Mortality After Complex Cancer Surgery—Patient, Volume, Hospital, or Social Determinants? Muhammad Musaab MunirSelamawit WoldesenbetTimothy M. Pawlik ASO Visual Abstract 10 February 2024 Pages: 2869 - 2870
ASO Visual Abstract: Access, Outcomes, and Costs Associated with Surgery for Malignancy Among People Experiencing Homelessness Casey M. SilverLauren M. JanczewskiRyan P. Merkow ASO Visual Abstract 17 January 2024 Pages: 2871 - 2872
Neoadjuvant Chemotherapy is Associated with Increased Risk of Postoperative DVT After Distal Pancreatectomy for Pancreatic Adenocarcinoma: a NSQIP Analysis Keenan J. RobbinsKenneth F. Newcomer Jr.William G. Hawkins Pancreatic Tumors 27 December 2023 Pages: 2873 - 2881
Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study Nan ZhangJin HeTimothy M. Pawlik Pancreatic Tumors 14 December 2023 Pages: 2882 - 2891
Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use—A Prospective Real-Life Study Salvatore PaiellaGiuseppe MalleoRoberto Salvia Pancreatic Tumors Open access 29 January 2024 Pages: 2892 - 2901
Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery Yohei AndoMohamad DboukMichael Goggins Pancreatic Tumors 06 February 2024 Pages: 2902 - 2912
Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery Shenghua BiYueping JiangXue Jing Pancreatic Tumors 06 February 2024 Pages: 2913 - 2924
Medicaid Expansion Increases Access for Rural and Impoverished Patients with Pancreatic Ductal Adenocarcinoma in Southern States Hemanth VenkateshTingting LiQuyen D. Chu Pancreatic Tumors 15 February 2024 Pages: 2925 - 2931
Prognostic Significance of Biologic Factors in Patients with a Modest Radiologic Response to Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancers: Impact of the Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Satoru MiyaharaHidenori TakahashiHidetoshi Eguchi Pancreatic Tumors 17 February 2024 Pages: 2932 - 2942
Early Versus Late Drainage Removal in Patients Who Underwent Pancreaticoduodenectomy: A Comprehensive Systematic Review and Meta-analysis of Randomized Controlled Trials Using Trial Sequential Analysis Claudio RicciDavide Giovanni GregoRiccardo Casadei Pancreatic Tumors Open access 24 February 2024 Pages: 2943 - 2950
Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced Bladder Cancer with Neoadjuvant Chemotherapy Minami OmuraTakeo KosakaMototsugu Oya Pancreatic Tumors Open access 20 February 2024 Pages: 2951 - 2958
ASO Author Reflections: Adjuvant Therapy for Resectable Pancreatic Cancer in the Real World—Not as Common as One Might Think Salvatore PaiellaGiuseppe MalleoRoberto Salvia ASO Author Reflections 13 February 2024 Pages: 2959 - 2960
ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery Yohei AndoMichael Goggins ASO Author Reflections 27 January 2024 Pages: 2961 - 2962
ASO Author Reflections: Impact of Myosteatosis and Creatinine-to-Cystatin C Ratio on Prognosis After Pancreatic Radical Surgery Shenghua BiXue Jing ASO Author Reflections 09 February 2024 Pages: 2963 - 2964
ASO Author Reflections: A Role for Extended VTE Prophylaxis After Neoadjuvant Therapy and Distal Pancreatectomy for Pancreatic Adenocarcinoma Keenan J. RobbinsWilliam G. Hawkins ASO Author Reflections 12 January 2024 Pages: 2965 - 2966
ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in Invasive Intraductal Mucinous Neoplasms of the Pancreas A. FogliatiMark J. Truty ASO Author Reflections Open access 14 March 2024 Pages: 2967 - 2968
ASO Author Reflections: Feasibility of Indocyanine Green Fluorescence Technique in Robotic Duodenum-Preserving Pancreatic Head Resection Yan LiBaoyong Zhou ASO Author Reflections 26 January 2024 Pages: 2969 - 2970
ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer Satoru MiyaharaHidenori TakahashiHidetoshi Eguchi ASO Author Reflections 16 February 2024 Pages: 2971 - 2972
ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors Nan ZhangXu-Feng ZhangTimothy M. Pawlik ASO Author Reflections 23 December 2023 Pages: 2973 - 2974
ASO Visual Abstract: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors—A Multi-Institutional Study Nan ZhangJin HeTimothy M. Pawlik ASO Visual Abstract 15 January 2024 Pages: 2975 - 2976
ASO Visual Abstract: Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use—A Prospective Real-Life Study Salvatore PaiellaGiuseppe MalleoRoberto Salvia ASO Visual Abstract 14 February 2024 Pages: 2977 - 2978
ASO Visual Abstract: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery Yohei AndoMohamad DboukMichael Goggins ASO Visual Abstract 14 February 2024 Pages: 2979 - 2980
ASO Visual Abstract: Prognostic Value of Myosteatosis and Creatinine-to-Cystatin-C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery Shenghua BiYueping JiangXue Jing ASO Visual Abstract 07 March 2024 Pages: 2981 - 2982
Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway Meiyue LouMasaaki IwatsukiHideo Baba Gastrointestinal Oncology 25 November 2023 Pages: 2983 - 2995
Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis Belinda H. McCullyKaiya KozumaRodney F. Pommier Gastrointestinal Oncology 16 January 2024 Pages: 2996 - 3002
Laparoscopic Dissection of Lymph Node Station 16—Why and How? William KawaharaEduardo A. VegaClaudius Conrad Gastrointestinal Oncology 27 February 2024 Pages: 3003 - 3004
Predictive Value of a New Muscle Parameter in Patients with Resectable Gastric Cancer: A Pooled Analysis of Three Prospective Trials Qing ZhongJiao-Bao HuangPing Li Gastrointestinal Oncology Open access 25 January 2024 Pages: 3005 - 3016
Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center Jolyn S. TaylorBryan M. FellmanSonali Thosani Gastrointestinal Oncology 12 February 2024 Pages: 3017 - 3023
Long-Term Outcome of Proximal Gastrectomy for Upper-Third Advanced Gastric and Siewert Type II Esophagogastric Junction Cancer Compared With Total Gastrectomy: A Propensity Score-Matched Analysis Seungho LeeYoon Soo ChaeHan-Kwang Yang Gastrointestinal Oncology Open access 19 February 2024 Pages: 3024 - 3030
ASO Author Reflections: Lymph Node Station 16 Status—Becoming a Student of Your Patients’ Cancer Oscar SalirrosasWilliam KawaharaClaudius Conrad ASO Author Reflections 29 February 2024 Pages: 3031 - 3032
ASO Author Reflections: COL8A1 Regulates Esophageal Squamous Carcinoma Jing HuSenxiang Yan ASO Author Reflections 15 February 2024 Pages: 3033 - 3033
ASO Visual Abstract: Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study Emma C. GertsenArjen van der VeenJelle P. Ruurda ASO Visual Abstract 19 January 2024 Pages: 3034 - 3035
ASO Visual Abstract: The Association between Intraoperative Compromised Intestinal Integrity and Postoperative Complications in Cancer Patients Sharon HendriksMonique HuismanJacco J. de Haan ASO Visual Abstract 17 January 2024 Pages: 3036 - 3037
ASO Visual Abstract: Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival—Results of a Blinded, Prospective Trial Nazanin KhajoueinejadElad SarfatyNoah A. Cohen ASO Visual Abstract 15 January 2024 Pages: 3038 - 3039
ASO Visual Abstract: Postoperative Complications After Neoadjuvant Chemotherapy Compared with Upfront Surgery in Gastric Adenocarcinoma—A Population-Based, Nationwide Study in Finland Emilia PutilaOlli Helminenthe FINEGO Group ASO Visual Abstract 29 January 2024 Pages: 3040 - 3041